LINC00638/hsa-miR-29b-3p axis-mediated high expression of CDCA4 correlates with tumor immune infiltration and hepatocellular carcinoma progression.
Translational cancer research(2023)
摘要
The low expression of CDCA4 significantly improves the prognosis of LIHC patients, and CDCA4 is a potential new biomarker for LIHC prognosis prediction. CDCA4-mediated LIHC carcinogenesis may involve tumor immune evasion and anti-tumor immunity. LINC00638/hsa-miR-29b-3p/CDCA4 should be a potential regulatory pathway in LIHC, and these findings provide a new perspective for the development of anti-cancer strategies in LIHC.
更多查看译文
关键词
Hepatocellular carcinoma, CDCA4, LINC00638, hsa-miR-29b-3p, prognostic biomarkers
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要